Home GlaxoSmithKline: Unfairly Beaten Given Strategic Direction
 

Keywords :   


GlaxoSmithKline: Unfairly Beaten Given Strategic Direction

2015-10-26 12:51:30| Biotech - Topix.net

GlaxoSmithKline PLC is a global pharmaceutical giant that is trading below intrinsic value. The company's real focus is on scale and innovation - providing much of the world with the drugs and medications it needs while containing an expansive list of patent-protected drugs in late stage development.

Tags: direction strategic beaten glaxosmithkline

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news

»
29.06Tropical Storm Beryl Public Advisory Number 3A
29.06Summary for Tropical Storm Beryl (AT2/AL022024)
29.06Tropical Storm Beryl Graphics
29.06Eastern North Pacific Tropical Weather Outlook
29.06Atlantic Tropical Weather Outlook
29.06Weekly Recap: PPG, Hempel, Beckers Group Top This Weeks Stories
29.06Tropical Storm Beryl Graphics
29.06Tropical Storm Beryl Forecast Discussion Number 3
More »